Introducing Flash BioSolutions : Spearheading advancements in Biopharmaceutical CDMO sector
Flash BioSolutions® strengthens its position in the Contract Development and Manufacturing Organisation (CDMO) market in the biopharmaceutical sector with a dynamic rebranding.
Toulouse, 28 march 2024 - Flash Therapeutics proudly unveils its transformation into Flash BioSolutions®, marking a strategic shift aimed at propelling its dominance in the competitive biopharmaceutical Contract Development and Manufacturing Organization (CDMO) landscape. This rebranding effort is accompanied by the introduction of a dynamic visual identity, emblematic of its relentless pursuit of innovation and its stature as a premier provider of bespoke development and manufacturing solutions in the realm of gene delivery for cell and gene therapy, and immunization.
The decision to reemerge as Flash BioSolutions® signifies a pivotal juncture in the company's journey, signifying its unwavering resolve to fortify its foothold in the global pharmaceutical outsourcing arena as an indomitable force.
"Our transition to Flash BioSolutions® epitomizes a pivotal evolutionary stride for our enterprise," declares Jérôme Bédier, the CEO of Flash BioSolutions®. "Our rebranded identity and revitalized visual representation epitomize our steadfast commitment to excellence, operational prowess, and groundbreaking innovation. We take immense pride in our legacy as trailblazers in gene delivery for cell and gene therapy and vaccination, and eagerly anticipate furnishing our clientele with avant-garde solutions to cater to their burgeoning demands."
The revamped visual identity of Flash BioSolutions® embodies a contemporary industrial aesthetic, emblematic of the company's resilience, vigor, and pledge to deliver unrivaled quality and innovation. A comprehensive overhaul of the website, slated for launch on July 1, will culminate the identity revamp initiative, enhancing the sales outreach strategies.
Under the distinguished banner of Flash BioSolutions®, the company remains steadfast in its commitment to furnishing cutting-edge development and contract manufacturing services for DNA and RNA gene delivery. This rebranding endeavor aligns seamlessly with the company's trajectory of expansion and global outreach to meet the escalating market exigencies.
About Flash BioSolutions® :
Flash BioSolutions® is a preeminent CDMO specializing in the industrial-scale production of DNA and RNA vectors for clientele within the domains of gene and cell therapy, and vaccine development. Bolstered by a robust manufacturing platform and validated processes honed over two decades, Flash BioSolutions® excels in delivering vectors of unmatched purity and concentration across research, pre-clinical, clinical, and commercial phases.
Contact :
Head of communication
Soraya Sandokchi
+33 582 955 546
soraya.sandokchi@flashbiosolutions.com
Download the Press Release :
English version